Clinical Trials Logo

Clinical Trial Summary

Based on previous results, the investigators considered that sedation quality, complications, and procedure outcomes may not be different, however, propofol alone titration may have a fast recovery time than BPS and cost-effectiveness than balanced propofol sedation (BPS). In present study, the investigators therefore evaluate the time and sedation quality of patient recovery, cost-effectiveness, complication, and procedure outcomes between propofol alone and BPS in therapeutic endoscopic retrograde cholangiopancreatography (ERCP).


Clinical Trial Description

Previous studies have shown that propofol is superior to traditional sedation regimens with benzodiazepines plus opioids in ERCP procedures. Propofol is a potent hypnotic drug with a short duration of action and consequently a more rapid recovery time for the patients compared with the available Benzodiazepines. Several prospective studies have shown that balanced propofol sedation (BPS) can be used safely and effectively for diagnostic endoscopy under the direction of a gastroenterologist. BPS which was originally described by Cohen et al, combines small incremental doses of propofol with single induction doses of benzodiazepines and opioids under the direction of a physician that is not an anesthesiologist. Because BPS usually targets moderate sedation, adequate amnesia and analgesia can be achieved with concomitant administration of benzodiazepines and opioids. It may cause synergism between propofol and midazolam and reduce dose of propofol. However, there was no proven benefit between propofol alone titrated to moderate level of sedation and BPS; propofol titration combination with benzodiazepines and fentanyl. ;


Study Design


Related Conditions & MeSH terms

  • Conscious Sedation Failure During Procedure

NCT number NCT01321047
Study type Interventional
Source Soon Chun Hyang University
Contact
Status Unknown status
Phase Phase 4
Start date April 2011
Completion date October 2011

See also
  Status Clinical Trial Phase
Recruiting NCT01990937 - Oral Midazolam for Sedation in Esophagogastroduodenoscopy(EGD) Phase 4
Completed NCT02512055 - Ketamine Tolerance in Children After Repeated Administrations During Radiotherapy Sessions Phase 4
Completed NCT05115578 - Remifentanil Effect-site Prediction by Algometry
Completed NCT00902395 - Efficacy of Moderate Sedation for Dental Treatment of Young Children Phase 4
Recruiting NCT04997967 - Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis Phase 4
Completed NCT02676206 - Music Therapy in Procedural Sedation in the Emergency Department N/A
Completed NCT02820051 - Non-anesthesiologist-administered Propofol During the Flexible Bronchoscopy N/A
Recruiting NCT02205502 - Lidocaine as Local Anesthetics in Children Under Ketamine Sedation Phase 4
Completed NCT00596050 - Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions Phase 4